dc.contributor.author | Aladro Benito, Yolanda | |
dc.contributor.author | Cerezo García, Marta | |
dc.contributor.author | Urtiaga, S. | |
dc.contributor.author | Galán Sánchez-Seco, V. | |
dc.contributor.author | Moreno Torres, I. | |
dc.contributor.author | Sabín Muñoz, Julia | |
dc.contributor.author | Gómez Moreno, Mayra | |
dc.contributor.author | Thuissard Vasallo, Israel John | |
dc.contributor.author | Sanz Rosa, David | |
dc.contributor.author | DMFCAM Study Group | |
dc.date.accessioned | 2021-06-16T15:33:20Z | |
dc.date.available | 2021-06-16T15:33:20Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Aladro Benito, Y., Cerezo García, M., Urtiaga, S., Galán Sánchez-Seco, V., Moreno Torres, I., Sabín Muñoz, J., Gómez, M., Thuissard, I., Sanz, D., & DMFCAM Study Group. (2018). P641- Dimethyl fumarate treatment in relapsing multiple sclerosis: A prospective observational postmarketing study of effectiveness. Multiple Sclerosis Journal, 24(S2), 322. | spa |
dc.identifier.issn | 1352-4585 | |
dc.identifier.issn | 1477-0970 | |
dc.identifier.uri | http://hdl.handle.net/11268/10163 | |
dc.description.sponsorship | Sin financiación | spa |
dc.language.iso | eng | spa |
dc.subject.other | Dimetilfumarato | spa |
dc.title | Dimethyl fumarate treatment in relapsing multiple sclerosis: a prospective observational postmarketing study of effectiveness | spa |
dc.type | conferenceObject | spa |
dc.description.impact | 5.649 JCR (2018) Q1, 23/199 Clinical Neurology | spa |
dc.description.impact | 1.742 SJR (2018) Q1, 25/171 Neurology | spa |
dc.description.impact | No data IDR 2018 | spa |
dc.rights.accessRights | closedAccess | spa |
dc.subject.unesco | Enfermedad del sistema nervioso | spa |
dc.subject.unesco | Tratamiento médico | spa |
dc.subject.unesco | Farmacología | spa |
dc.description.filiation | UEM | spa |
dc.peerreviewed | Si | spa |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |